The People Who Drive BioFabUSA

See ARMI|BioFabUSA’s dedicated Leadership Team, Board of Directors, Stakeholder Council and Leadership Advisory Council.



Executive Director & Chairman of the Board, ARMI

Maureen Toohey

Deputy Executive Director & Secretary of the Board

Thomas Bollenbach, Ph.D.

Chief Technology Officer

Jim Scott

Chief Operating Officer

Richard McFarland

Ph.D., M.D., Chief Regulatory Officer, BioFabUSA

Ned Gordon

Chief Operating Officer, BioFabUSA

Stefany Shaheen

Chief Strategy Officer, BioFabUSA

David Rogers

Chief Development Officer, ARMI

Julie Lenzer

Chief Innovation Officer, BioFabUSA

Mike Decelle

Chief Workforce Officer, BioFabUSA

Board of Directors

Like-minded people—who are from different spheres but have changed the world in their own ways—make up ARMI’s board of directors.


ARMI Executive Director, DEKA CEO, serial inventor and FIRST founder

Martine Rothblatt

United Therapeutics CEO and Sirius Satellite Radio founder

John Abele

Boston Scientific founder and medical device pioneer

Dr. Jim Weinstein

Senior Vice President for Microsoft Healthcare, and former CEO of Dartmouth-Hitchcock

Laurie Leshin

Worcester Polytechnic Institute President

Blake Moret

Rockwell Automation CEO and veterans and workforce-development champion

Stakeholder Council

The Stakeholder Council is a combination of ARMI’s board of directors and highly relevant leadership at the U.S. Department of Defense.

Dean Kamen, DEKA Research and Development

Martine Rothblatt, United Therapeutics

John Abele, Boston Scientific

Lt. Col. Eaton, U.S. Army

Dr. Lloyd Rose, USAMMDA

Dawn Rosarius, MRDC

Jim Weinstein, Microsoft

Laurie Leshin, Worcester Polytechnic Institute

Blake Moret, Rockwell Automation

Tracy Frost, U.S. Department of Defense

Dr. Michelle Rozo, U.S. Department of Defense

Leadership Advisory Council

The Leadership Advisory Council provides industry expertise and strategic guidance to the stakeholder council. Members of the council are elected by BioFabUSA’s membership.

Alan Lotvin, CVS Health

Allen Comer, Stratatech

Amy Peterson, University of Massachusetts, Lowell

Atta Behfar, Mayo Clinic

Brian Hawkins, Pluristyx

Caralynn Nowinski Collens, Dimension Inx

Carolyn Yeago, Georgia Tech

Cato Laurencin, University of Connecticut

David Brafman, Arizona State University

David Vasko, Rockwell Automation

Doris Taylor, OrganaMet Bio

Esther Latres, JDRF

George Christ, University of Virginia

James Sherley, Asymmetrex

Jane Lebkowski, Regenerative Patch Technologies

Jian Ling, Southwest Research Institute

Kaiming Ye, Binghamton University

Kyle Christianson, Embody

Lisa Larkin, STEL Technologies

Marcie Black, Advanced Silicon Group

Maria Pascale, MPR & Associates

Marian McCord, University of New Hampshire

Marsha Rolle, Worcester Polytechnic Institute

Michael Golway, Advanced Solutions Life Sciences

Paul Goodwin, Cytiva

Priya Baraniak, OrganaBio

Sarinder”Ik” Bhumiratana, Epibone

Stu Jacobson, DEKA R&D Corporation